A first? COVID antibody therapy with full-year protection is up for FDA authorization: AZD7442, is designed to be used as a preventive measure to boost immunity for up to one year after a single, intramuscular injection

A first? COVID antibody therapy with full-year protection is up for FDA authorization: AZD7442, is designed to be used as a preventive measure to boost immunity for up to one year after a single, intramuscular injection: https://ift.tt/3Btm0d0 Read more... https://ift.tt/3akpbrF